Human Molecular Genetics, 2003, Vol. 12, No. 2 99-109
© 2003 Oxford University Press
Nonsense mediated decay downregulates conserved alternatively spliced ABCC4 transcripts bearing nonsense codons
St Jude Children's Research Hospital, Department of Pharmaceutical Sciences, Memphis, TN, USA and Departments of Ophthalmology and Pathology Columbia University, New York, USA
Received August 30, 2002; Accepted October 31, 2002
Drug transporters are an important part of the defense of cells against cytotoxic agents. One major group of transporters is known as multidrug resistance associated proteins (MRP; ABCC gene family). The MRPs belong to the ATP binding cassette transporter superfamily. One family member, ABCC4 (also known as MRP4) functions as a cellular efflux pump for anti-HIV drugs, such as 9-(2-phoshoenylmethoxyethyl) adenine and azido-thymidine-monophosphate, an antiviral nucleotide, ganciclovir-monophosphate, and anti-cancer agents such as thiopurines. We isolated a ABCC4 cDNA encoding a non-functional protein, owing to an insertion, and subsequently determined the ABCC4 gene structure. This analysis revealed that the insertion was attributed to two additional exons that would be predicted to produce premature termination codons (PTC) in ABCC4. The highly similar mouse Abcc4 gene also contained these exons, which were remarkable because their size and sequence identity were much higher than the overall similarity between these genes. Further, a comparison of human, monkey and rodent ABCC4 genes revealed that these same PTC-producing exons were also highly conserved in evolution. As all the ABCC4 mRNA containing these PTC exons might produce nonsense mRNA, we further tested the hypothesis that these mRNAs were targets of nonsense-mediated mRNA decay (NMD). Protein synthesis inhibition selectively stabilized PTC containing ABCC4 transcripts in human, monkey and rodent cell lines. Moreover, the amount of PTC-containing ABCC4 transcripts was critically dependent upon protein synthesis, as removal of the inhibitor dramatically decreased expression, which correlated with the resumption of protein synthesis. These are the first studies to indicate that the highly conserved PTC exons of the ABCC4 gene may dictate its expression.
* To whom correspondence should be addressed. Fax: +1 9015256869; Email: john.schuetz{at}stjude.org
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Melamud and J. Moult Structural implication of splicing stochastics Nucleic Acids Res., August 1, 2009; 37(14): 4862 - 4872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Melamud and J. Moult Stochastic noise in splicing machinery Nucleic Acids Res., August 1, 2009; 37(14): 4873 - 4886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Lueck, C. Lungu, A. Mankodi, R. J. Osborne, S. L. Welle, R. T. Dirksen, and C. A. Thornton Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1 Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1291 - C1297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Hyvonen, A. Uimari, T. A. Keinanen, S. Heikkinen, R. Pellinen, T. Wahlfors, A. Korhonen, A. Narvanen, J. Wahlfors, L. Alhonen, et al. Polyamine-regulated unproductive splicing and translation of spermidine/spermine N1-acetyltransferase RNA, August 1, 2006; 12(8): 1569 - 1582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wittmann, E. M. Hol, and H.-M. Jack hUPF2 Silencing Identifies Physiologic Substrates of Mammalian Nonsense-Mediated mRNA Decay Mol. Cell. Biol., February 15, 2006; 26(4): 1272 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cuccurese, G. Russo, A. Russo, and C. Pietropaolo Alternative splicing and nonsense-mediated mRNA decay regulate mammalian ribosomal gene expression Nucleic Acids Res., October 27, 2005; 33(18): 5965 - 5977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Busi and T. Cresteil CYP3A5 mRNA Degradation by Nonsense-Mediated mRNA Decay Mol. Pharmacol., September 1, 2005; 68(3): 808 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Leggas, M. Adachi, G. L. Scheffer, D. Sun, P. Wielinga, G. Du, K. E. Mercer, Y. Zhuang, J. C. Panetta, B. Johnston, et al. Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy Mol. Cell. Biol., September 1, 2004; 24(17): 7612 - 7621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Assem, E. G. Schuetz, M. Leggas, D. Sun, K. Yasuda, G. Reid, N. Zelcer, M. Adachi, S. Strom, R. M. Evans, et al. Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice J. Biol. Chem., May 21, 2004; 279(21): 22250 - 22257. [Abstract] [Full Text] [PDF]
|
|